Testing for mutations in the BRCA1 and BRCA2 genes among high-risk breast cancer patients has become a routine practice ...
...BRCA1, a locus previously linked to breast and ovarian cancer predisposition. Its protein product (also known as TBPIP a...
...BRCA1 mutation carriers status, significantly decreased breast cancer risk was found for allele contrast model. But sign...
...BRCA1/2-negative breast cancer.,These findings confirm an increased cancer risk associated with the G84E mutation in the...
...BRCA1 in patients with gastric cancer undergoing surgery and platinum-based adjuvant chemotherapy. BRCA1 protein express...
...BRCA1 and BRCA2 genes combined with a variant prioritization pipeline, designed to minimize the number of false-positive...
...BRCA1). MCPH1 containing BRCT domain has been suggested as a tumor suppressor in breast and ovarian cancers. We analyzed...
...BRCA1 and BRCA2, respectively, relative to salpingectomy alone. Bilateral salpingo-oophorectomy yielded the lowest numbe...
...BRCA1 staining was noted in all 5 cases with BRCA1 germline mutations, in 3 (60%) of 5 with BRCA1 somatic mutations, and...
...BRCA1, BRCA2 and non-BRCA1/2) and to identify markers of diagnostic value that might help to select more specific treatm...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
